<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s13756-019-0563-x</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">13756</journal-id><journal-title-group><journal-title>Antimicrobial Resistance &amp; Infection Control</journal-title><abbrev-journal-title abbrev-type="publisher">Antimicrob Resist Infect Control</abbrev-journal-title></journal-title-group><issn pub-type="epub">2047-2994</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s13756-019-0563-x</article-id><article-id pub-id-type="manuscript">563</article-id><article-id pub-id-type="doi">10.1186/s13756-019-0563-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title xml:lang="en">New genetic context of <italic>lnu(B)</italic> composed of two multi-resistance gene clusters in clinical <italic>Streptococcus agalactiae</italic> ST-19 strains</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Zhou</surname><given-names>Kaixin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Zhu</surname><given-names>Dongan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Tao</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Xie</surname><given-names>Lianyan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Han</surname><given-names>Lizhong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au6"><name><surname>Zhang</surname><given-names>Yibo</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="corresp" rid="IDs137560190563x_cor6">f</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au7"><name><surname>Sun</surname><given-names>Jingyong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs137560190563x_cor7">g</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution content-type="org-division">Department of Clinical Microbiology</institution><institution content-type="org-name">Ruijin Hospital, Shanghai Jiaotong University School of Medicine</institution></institution-wrap><addr-line content-type="street">197 Ruijin 2nd Road</addr-line><addr-line content-type="postcode">200025</addr-line><addr-line content-type="city">Shanghai</addr-line><country country="CN">China</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.477929.6</institution-id><institution content-type="org-division">Department of Clinical Laboratory, Shanghai Pudong Hospital</institution><institution content-type="org-name">Fudan University Pudong Medical Center</institution></institution-wrap><addr-line content-type="street">2800 Gongwei Road, Huinan Town</addr-line><addr-line content-type="postcode">201399</addr-line><addr-line content-type="city">Pudong, Shanghai</addr-line><country country="CN">China</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution content-type="org-division">Department of Hospital infection control</institution><institution content-type="org-name">Ruijin Hospital, Shanghai Jiaotong University School of Medicine</institution></institution-wrap><addr-line content-type="street">197 Ruijin 2nd Road</addr-line><addr-line content-type="postcode">200025</addr-line><addr-line content-type="city">Shanghai</addr-line><country country="CN">China</country></aff></contrib-group><author-notes><corresp id="IDs137560190563x_cor6"><label>f</label><email>yiboguan@126.com</email></corresp><corresp id="IDs137560190563x_cor7"><label>g</label><email>13671578899@126.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>7</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>8</volume><issue seq="116">1</issue><elocation-id>117</elocation-id><history><date date-type="registration"><day>18</day><month>6</month><year>2019</year></date><date date-type="received"><day>18</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>18</day><month>6</month><year>2019</year></date><date date-type="online"><day>15</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Clindamycin is a lincosamide antibiotic used to treat staphylococcal and streptococcal infections. Reports of clinical <italic>Streptococcus agalactiae</italic> isolates with the rare lincosamide resistance/macrolide susceptibility (L<sup>R</sup>/M<sup>S</sup>) phenotype are increasing worldwide. In this study, we characterised three clinical <italic>S. agalactiae</italic> strains with the unusual L phenotype from China.</p></sec><sec id="ASec2"><title>Methods</title><p id="Par2">Three clinical <italic>S. agalactiae</italic> strains, Sag3, Sag27 and Sag4104, with the L phenotype were identified from 186 isolates collected from 2016 to 2018 in Shanghai, China. The MICs of clindamycin, erythromycin, tetracycline, levofloxacin, and penicillin were determined using Etest. PCR for the <italic>lnu(B)</italic> gene was conducted. Whole genome sequencing and sequence analysis were carried out to investigate the genetic context of <italic>lnu(B)</italic>. Efforts to transfer lincomycin resistance by conjugation and to identify the circular form by inverse PCR were made.</p></sec><sec id="ASec3"><title>Results</title><p id="Par3">Sag3, Sag27, and Sag4104 were susceptible to erythromycin (MIC ≤0.25 mg/L) but resistant to clindamycin (MIC ≥1 mg/L). <italic>lnu(B)</italic> was found to be responsible for the L phenotype. <italic>lnu(B)</italic> in Sag3 and Sag27 were chromosomally located in an <italic>aadE-spw-lsa(E)-lnu(B)</italic> resistance gene cluster adjacent to an upstream 7-kb <italic>tet(L)-cat</italic> resistance gene cluster. Two resistance gene clusters were flanked by the IS6-like element, IS1216. Sag4104 only contained partial genes of <italic>aadE-spw-lsa(E)-lnu(B)</italic> resistance gene cluster and was also flanked by IS1216.</p></sec><sec id="ASec4"><title>Conclusion</title><p id="Par4">These results established the presence of the L phenotype associated with <italic>lnu(B)</italic> in clinical <italic>S. agalactiae</italic> isolates in China. The <italic>lnu(B)</italic>-containing multi-resistance gene cluster possibly acts as a composite transposon flanked by IS1216 and as a vehicle for the dissemination of multidrug resistance among <italic>S. agalactiae</italic>.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>S. agalactiae</italic></kwd><kwd><italic>lnu(B)</italic></kwd><kwd>L phenotype</kwd><kwd>Composite transposon</kwd><kwd>IS1216</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Outstanding Leaders Training Program of Pudong Health Bureau of Shanghai</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">PWRI2016-04</award-id><principal-award-recipient><name><surname>Zhu</surname><given-names>Dongan</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution>Gaofeng Clinical Medicine Grant Support</institution></institution-wrap></funding-source><award-id award-type="FundRef grant">2017269</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yibo</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>2</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>6</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>18</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/13756_2019_Article_563.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Biomedicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Medical Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Drug Resistance</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Infectious Diseases</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Biomedical and Life Sciences</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="AuthorContribution"><p>Kaixin zhou was the fisrt author and Dongan Zhu was the co-first author.</p></notes></front><body><sec id="Sec1"><title>Background</title><p id="Par12"><italic>Streptococcus agalactiae</italic> (group B streptococcus) is a leading cause of neonatal sepsis, meningitis, and pneumonia in many countries. It is also an important pathogen among pregnant women, immunocompromised adults, as well as the elderly [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par13">The lincosamide class of antibacterial agents was first characterised in the 1960s and is now among the twenty most important antibiotic compounds [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. The most clinically relevant lincosamide, clindamycin, is frequently used to treat staphylococcal and streptococcal infections. It is also a feasible option for the treatment of β-lactamase-producing pathogens and important protozoal diseases, such as malaria [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Clindamycin treatment has been limited by antimicrobial resistance and gastrointestinal side effects. However, it is effective for the treatment of methicillin-resistant <italic>Staphylococcus aureus</italic> [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], especially for the empirical treatment of CA-MRSA for outpatients with skin and soft tissue infection.</p><p id="Par14">Resistance to macrolides, lincosamides, and streptogramin B mediated by <italic>erm</italic> or <italic>mef</italic> is quite common in streptococci, while isolates characterized by the combination of phenotypic lincosamide resistance and macrolide susceptibility (L<sup>R</sup>/M<sup>S</sup>) are rare. Specific resistance to lincosamides is mediated by members of the <italic>lnu</italic> (previously <italic>lin</italic>) gene family, which encode nucleotidyltransferases that catalyse the adenylation of lincosamides [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Six types of <italic>lnu</italic>—<italic>lnu(A), lnu(B), lnu(C), lnu(D), lnu(E),</italic> and <italic>lnu(F)</italic>—have been discovered to date [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. Reports of <italic>Streptococcus agalactiae</italic> with the unusual L phenotype have recently increased in the United States [<xref ref-type="bibr" rid="CR8">8</xref>], Canada [<xref ref-type="bibr" rid="CR11">11</xref>], Spain [<xref ref-type="bibr" rid="CR14">14</xref>], and other countries.</p><p id="Par15">In this study, three clinical <italic>S. agalactiae</italic> isolates of the unusual L phenotype were identified. The phenotype was mediated by a nucleotidyltransferase expressed by <italic>lnu(B)</italic>. We investigated the genetic context of <italic>lnu(B)</italic> and estimated its possible formation in <italic>S. agalactiae</italic>. To the best of our knowledge, this is the first report on the genetic context of <italic>lnu(B)</italic> gene in clinical <italic>S. agalactiae</italic> isolates in China.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><sec id="Sec3"><title>Bacterial strains and lincosamide resistance gene detection</title><p id="Par16">Three clinical <italic>S. agalactiae</italic> strains with the unusual resistance phenotype (L<sup>R</sup>/M<sup>S</sup>), Sag3, Sag27 and Sag4104, were identified from 186 clinical strains collected from various sample types (including midstream urine, vaginal secretion, and blood) between 2016 to 2018 in Shanghai, China (Ruijin Hospital, School of Medicine, Shanghai Jiaotong University). All the isolates were identified using MALDI-TOF MS (bioMérieux, France), and the minimum inhibitory concentrations (MICs) were determined using VITEK2 automated systems (BioMérieux, France). Sag3 was isolated from the vaginal secretion of a pregnant female outpatient in 2016; Sag27 was isolated from perianal region of a female inpatient after bone marrow transplantation in 2018; and Sag4104 was isolated from urine sample of a female inpatient in 2018. Sag3, Sag27 and Sag4104 were investigated for the lincosamide resistance gene, <italic>lnu(B)</italic>, by PCR (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>PCR primers used in this study</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Primer</p></th><th><p>Sequence (5′–3′)</p></th><th><p>Product size (bp)</p></th></tr></thead><tbody><tr><td><p>lnuB-F</p></td><td><p>ACCAAAGGAGAAGGTGACCAA</p></td><td char="." align="char" rowspan="2"><p>584</p></td></tr><tr><td><p>lnuB-R</p></td><td><p>ACCTTATCTAATCGAGCAGTGGT</p></td></tr><tr><td><p>3-F</p></td><td><p>TTCGATTCCTCGTGCCTGAC</p></td><td char="." align="char" rowspan="2"><p>1877</p></td></tr><tr><td><p>3-R</p></td><td><p>AAGCGAGGTCGTAACTGGTG</p></td></tr><tr><td><p>Rev-1-F</p></td><td><p>ACGCCCTGTAACGCTTGTAA</p></td><td char="." align="char" rowspan="3"><p>2571</p></td></tr><tr><td><p>Rev-1-R</p></td><td><p>TGCAAAGACCACTGCTCGAT</p></td></tr><tr><td><p>Rev-2-F</p></td><td><p>GGTGAACGAAAGCCCACCTA</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec4"><title>Antimicrobial susceptibility test and conjugal transfer experiments</title><p id="Par17">The minimum inhibitory concentrations (MICs) of clindamycin, erythromycin, tetracycline, levofloxacin, and penicillin were determined using the Etest (bioMérieux, Marcy-l’Étoile, France). The results were interpreted based on the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [<xref ref-type="bibr" rid="CR15">15</xref>]. The transfer of lincomycin resistance was attempted from Sag3, Sag27, and Sag4104 (L<sup>R</sup>/M<sup>S</sup>) to clinical <italic>S. agalactiae</italic> strains (L<sup>S</sup>/M<sup>R</sup>) by the filter-mating method. Selection was performed with erythromycin (1 μg/mL) and lincomycin (1 μg/mL).</p></sec><sec id="Sec5"><title>Pulsed-field gel electrophoresis</title><p id="Par18">Sag3, Sag27, and Sag4104 were digested with <italic>Sma</italic>I endonuclease and subjected to pulsed-field gel electrophoresis (PFGE), as described in previous studies [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Briefly, two or three colonies were picked from a fresh plate of overnight growth and incubated in Todd-Hewitt broth for 5 h at 35 °C; this suspension was centrifuged and the pellet was re-suspended in Tris-NaCl buffer. The agarose-bacterium plugs were made and incubated overnight at 35 °C in lysis solution. The plugs were washed for several times and digested with suitable nuclease. The chromosomal digests were separated by PFGE. Pulsotypes were clustered on the basis of a cut-off of 70% similarity.</p></sec><sec id="Sec6"><title>DNA sequencing and analysis</title><p id="Par19">Genomic DNA was extracted using the QIAGEN Midi Kit (Qiagen, Hilden, Germany). The DNA of Sag27 was sequenced using the PacBio RS II (Pacific Biosciences, Menlo Park, CA, USA). The reads were de novo assembled using HGAP 3.0 SMRT™ Pipe. Sag3 and Sag4104 were sequenced using the Illumina HiSeq sequencing approach. SOAP de novo (<ext-link xlink:href="http://soap.genomics.org.cn/" ext-link-type="url">http://soap.genomics.org.cn/</ext-link>, v2.01) was used for genome assembly. Sequence similarity was evaluated by BLAST searches (<ext-link xlink:href="http://www.ncbi.nlm.nih.gov" ext-link-type="url">http://www.ncbi.nlm.nih.gov</ext-link>). Open reading frames (ORFs) were predicted using ORF Finder (<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/orffinder/" ext-link-type="url">https://www.ncbi.nlm.nih.gov/orffinder/</ext-link>). Protein-coding genes were initially identified and annotated using RAST. Antimicrobial resistance genes were identified using ResFinder (<ext-link xlink:href="https://cge.cbs.dtu.dk/services/ResFinder/" ext-link-type="url">https://cge.cbs.dtu.dk/services/ResFinder/</ext-link>). Multi-locus sequence typing was identified using MLST 2.0 (<ext-link xlink:href="https://cge.cbs.dtu.dk/services/MLST/" ext-link-type="url">https://cge.cbs.dtu.dk/services/MLST/</ext-link>).</p></sec><sec id="Sec7"><title>Gap closure, circularisation, and integration site of the lnu(B)-carrying fragment</title><p id="Par20">PCR with primers 3-F and 3-R was used to close the gap between two scaffolds around the <italic>lnu(B)</italic>-carrying fragment in Sag37. Outward-directed primers (Rev-1-F, Rev-1-R, Rev-2-F, and 3-R) were used to detect the circular form of the IS1216-flanked fragments (Table <xref rid="Tab1" ref-type="table">1</xref>; Fig. <xref rid="Fig2" ref-type="fig">2</xref>).</p></sec><sec id="Sec8"><title>Nucleotide sequence accession numbers</title><p id="Par21">The nucleotide sequences of Sag27/Sag4104 and the <italic>lnu(B)</italic>-carrying fragment of Sag3 have been deposited at DDBJ/ENA/GenBank under the accession numbers CP031556, SMRZ00000000, and MK102985, respectively.</p></sec></sec><sec id="Sec9" sec-type="results"><title>Results</title><sec id="Sec10"><title>Characterisation of rare L<sup>R</sup>/M<sup>S</sup><italic>S. agalactiae</italic> isolates</title><p id="Par22">The strains were susceptible (MIC ≤0.25 mg/L) to erythromycin, but resistant to clindamycin (MIC ≥1 mg/L). All the strains were classified as ST-19 and serotype III. PCR and sequencing results showed that strains contained the lincosamide resistance gene, <italic>lnu(B)</italic>. These results, isolation data, and resistance genes are summarised in Table <xref rid="Tab2" ref-type="table">2</xref>. <italic>Sma</italic>I-PFGE analysis indicated that the three strains were of different pulsotypes (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Relevant features of the two strains Sag3 and Sag27</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"><p>Strain</p></th><th rowspan="2"><p>Year</p></th><th rowspan="2"><p>Source</p></th><th rowspan="2"><p>ST</p></th><th rowspan="2"><p>Serotype</p></th><th colspan="5"><p>MIC (mg/L)</p></th><th rowspan="2"><p>Resistance genes</p></th></tr><tr><th><p>E</p></th><th><p>CM</p></th><th><p>TE</p></th><th><p>LEV</p></th><th><p>P</p></th></tr></thead><tbody><tr><td><p>Sag3</p></td><td><p>2016</p></td><td><p>Vaginal secretion</p></td><td><p>19</p></td><td><p>III</p></td><td><p>0.125</p></td><td><p>8</p></td><td><p>8</p></td><td><p>0.50</p></td><td><p>0.016</p></td><td><p><italic>lnu(B),lsa(E), aadE, cat, tet(L), tet(M)</italic></p></td></tr><tr><td><p>Sag27</p></td><td><p>2018</p></td><td><p>Perianal region</p></td><td><p>19</p></td><td><p>III</p></td><td><p>0.094</p></td><td><p>12</p></td><td><p>16</p></td><td><p>0.50</p></td><td><p>0.032</p></td><td><p><italic>lnu(B), aadE, cat, tet(L), tet(O)</italic></p></td></tr><tr><td><p>Sag4104</p></td><td><p>2018</p></td><td><p>urine</p></td><td><p>19</p></td><td><p>III</p></td><td><p>0.125</p></td><td><p>8</p></td><td><p>6</p></td><td><p>0.50</p></td><td><p>0.16</p></td><td><p><italic>lnu(B),lsa(E), tet(M)</italic></p></td></tr></tbody></table><table-wrap-foot><p><italic>E</italic> erythromycin, <italic>CM</italic> clindamycin, <italic>TE</italic> tetracycline, <italic>LEV</italic> levofloxacin, <italic>P</italic> penicillin</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Pulsed-field gel electrophoresis (PFGE) profiles of <italic>S. agalactiae</italic> Sag3, Sag27, and Sag4104. PFGE analysis showed that three strains were of different pulsotypes. M, <italic>Salmonella enterica</italic> serotype Braenderup H9812 was digested with <italic>Xba</italic>I and used as a molecular size marker</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13756_2019_563_Fig1_HTML.png" id="MO1"/></p></fig></p></sec><sec id="Sec11"><title>General genomic features and genetic context of lnu(B)</title><p id="Par23">In the whole genome sequencing analysis, 54 total scaffolds were obtained for Sag3 with a total length of 2,292,988 bp, while 53 scaffolds were obtained for Sag4104 with a total length of 2,188,850 bp. The average G + C content of Sag3 and Sag4104 was 35.88 and 35.59%, respectively. The genome of Sag27 comprised a single circular chromosome of 2,205,229 bp in length; the average G + C content was 35.71% and a total of 2229 protein-coding sequences (CDS) were predicted.</p><p id="Par24">Extensive sequence analyses revealed two <italic>lnu(B)</italic>-carrying fragments in both Sag3 and Sag27. In Sag 27 (CP031556, 136,248–157,861 bp), <italic>lnu(B)</italic> was embedded in the <italic>aadE-spw-lsa(E)-lnu(B)</italic> resistance gene cluster and an additional 7-kb <italic>tet(L)-cat</italic> resistance gene cluster was detected immediately upstream. The two clusters were flanked by the IS6-like element, IS1216. The whole fragment was 21,614 bp. A group II intron inserted into the topoisomerase I gene (<italic>topo</italic>) was also identified in the fragment, with high similarity to the group II intron <italic>En.fm.</italic>I2 first found on the <italic>Enterococcus faecium</italic> plasmid pVEF4 [<xref ref-type="bibr" rid="CR18">18</xref>]. Sag4104 only contained partial genes of <italic>aadE-spw-lsa(E)-lnu(B)</italic> resistance gene cluster, including <italic>lsa(E)</italic> and <italic>lnu(B)</italic>. The gene cluster was also flanked by the IS6-like element, IS1216.</p><p id="Par25">Comparative genome analyses identified two scaffolds in Sag3 that shared high similarity and contained all resistance genes in the abovementioned fragment in Sag27. Gap closure was performed by PCR. The final spliced fragment was 256,867 bp. Although the major drug resistance clusters were similar, there were slight differences at the head and tail regions between the two fragments. There were four additional ORFs at the tail of the fragment in Sag3 (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The gene cluster in Sag4104 also shared high similarity with the fragment in Sag3 and Sag27.</p></sec><sec id="Sec12"><title>Transferability</title><p id="Par26">Since insertion sequences (IS) can move resistance genes as part of a composite transposon, a region bound by two copies of the same or related IS that can move as a single unit [<xref ref-type="bibr" rid="CR19">19</xref>], several conjugal transfer experiments between Sag3/Sag27/Sag4014 and different recipient cells were performed. Even after numerous attempts, no transconjugant was obtained. This indicated that mobilisation of the <italic>lnu(B)</italic>-carrying fragments does not occur in <italic>S. agalactiae</italic>, or occurs at very low frequencies. Inverse PCR was also performed to identify the circular form of the fragments but was unsuccessful.</p></sec></sec><sec id="Sec13" sec-type="discussion"><title>Discussion</title><p id="Par27">Erythromycin and clindamycin are recommended for patients who are allergic to β-lactams for the prevention or treatment of <italic>S. agalactiae</italic> infections [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Erythromycin and clindamycin resistance rates in <italic>S. agalactiae</italic> are rising in several countries, with slight geographical variations, including the United States, Spain, and China [<xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. Resistance to clindamycin in the absence of erythromycin resistance is relatively rare in <italic>S. agalactiae</italic>; however, the frequency of this phenotype has also increased in recent years [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Reports of <italic>Streptococcus agalactiae</italic> with the unusual L phenotype have recently increased in the United States [<xref ref-type="bibr" rid="CR8">8</xref>], Canada [<xref ref-type="bibr" rid="CR11">11</xref>], Spain [<xref ref-type="bibr" rid="CR14">14</xref>], and other countries. We reported three clinical <italic>S. agalactiae</italic> strains with the unusual L phenotype mediated by <italic>lnu(B)</italic> in China and further investigated the gene context of <italic>lnu(B)</italic>.</p><p id="Par28"><italic>lnu(B)</italic> was chromosomally embedded in both Sag3 and Sag27 as part of a <italic>aadE-spw-lsa(E)-lnu(B)</italic> resistance gene cluster, while Sag4104 only contained partial genes of <italic>aadE-spw-lsa(E)-lnu(B)</italic> resistance gene cluster, including <italic>lsa(E)</italic> and <italic>lnu(B)</italic>. The <italic>lnu(B)</italic>-containing multi-resistance gene cluster in this study showed high similarity to transposable elements found in <italic>S. agalactiae, Staphylococcus aureus, E. faecium,</italic> and other taxa (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), with some differences in insertion sequences in the head and tail (flanked by IS1216, IS1257, or IS1542).</p><p id="Par29">Interestingly, the location of the gene cluster differs among species. The gene cluster was found on plasmids in <italic>E. faecium</italic> (pXD5 [<xref ref-type="bibr" rid="CR27">27</xref>], pEF418, etc.) and was embedded either in the chromosome or on the plasmid in <italic>S. aureus</italic> [<xref ref-type="bibr" rid="CR28">28</xref>]. The gene clusters were only located on the chromosomes of <italic>S. agalactiae</italic>. In particular, the <italic>lnu(B)</italic>-containing gene cluster was embedded in an integrative and conjugative element (ICE) in CUGBS591 (accession number: CP021862). The transferability of this ICE was not indicated. Coincidentally, ICESsuNC28, a mobile genetic element identified in <italic>S. suis</italic> harbouring the <italic>spw-aadE-lnu(B)-lsa(E)</italic> multidrug resistance cluster is capable of intraspecific transfer by conjugation [<xref ref-type="bibr" rid="CR7">7</xref>]. The multidrug resistance cluster likely originated in enterococcal strains and was acquired by staphylococcal and streptococcal species [<xref ref-type="bibr" rid="CR27">27</xref>]. Although we failed to prove that the <italic>lnu(B)</italic>-containing gene cluster can be transferred by mating experiments, data analysis suggested that interspecific exchange is possible. Further research is needed to characterise the mechanisms underlying its transfer.</p><p id="Par30">An additional 7-kb <italic>tet(L)-cat</italic> resistance gene cluster was detected immediately upstream of the <italic>lnu(B)</italic>-containing multi-resistance gene cluster in Sag3 and Sag4104. It showed high similarity to a plasmid of <italic>E. faecium</italic> strain LS170308 (CP025078). Few sequences in the GenBank database show high similarity to the <italic>tet(L)-cat</italic> resistance gene cluster. Although the <italic>lnu(B)</italic>-containing multi-resistance gene cluster has been found in several species, the two gene clusters are not linked together in previously reported genomes. The tandem sequence was identified in both Sag3 and Sag27, indicating that it can be transferred as a unit among <italic>S. agalactiae</italic>.</p><p id="Par31">With respect to the formation of this multi-drug resistance gene, the <italic>lnu(B)</italic>-containing and <italic>tet(L)-cat</italic> resistance gene clusters both originated from plasmids of enterococcal strains. Different insertion sequences (IS1216, IS257, etc.) in the plasmids formed a “translocatable unit” (TU) bound by two copies of the same IS, which can move as a single unit into plasmids or the chromosome [<xref ref-type="bibr" rid="CR19">19</xref>]. A TU is preferentially inserted next to an existing copy of the same IS in a recipient molecule via a conserved process [<xref ref-type="bibr" rid="CR19">19</xref>], which can explain why the <italic>tet(L)-cat</italic> resistance gene cluster flanked by IS1216 was detected immediately upstream of the <italic>lnu(B)</italic>-containing gene cluster. Thus, once a TU with a resistance gene(s) is inserted, it might become a recruiter for other TUs, resulting in the formation a multi-drug resistance gene cluster.</p><p id="Par32">Sag3, Sag27, and Sag4104 were ST-19, the most frequent ST of <italic>S. agalactiae</italic> in China [<xref ref-type="bibr" rid="CR29">29</xref>]. The genome of Sag27 showed striking similarity (94%) to that of another <italic>S. agalactiae</italic> strain, Sag158 (accession number: CP019979), previously described by us [<xref ref-type="bibr" rid="CR30">30</xref>] (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Three segmental insertions in Sag27 were detected in comparison with Sag158, including the lnu(B)-containing fragment (135–160 kb), ICESt1-related genes (1025–1050 kb), and ICESde3396 (2119–2184 kb). (Figure <xref rid="Fig3" ref-type="fig">3</xref>) The <italic>lnu(B)</italic>-containing multi-resistance gene cluster possibly acts as a composite transposon flanked by IS1216 and as a vehicle for the dissemination of multidrug resistance among ST-19 <italic>S. agalactiae</italic>.<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>Schematic representation, drawn to scale, of the <italic>lnu(B)</italic>-containing multi-resistance gene clusters in Sag3/Sag27/Sag4104 and a comparison of linear DNA against the corresponding regions in different species, including <italic>S. agalactiae</italic>, <italic>Staphylococcus aureus,</italic> and <italic>E. faecium</italic>. The resistance genes are indicated by blue arrows and the insertion sequences are indicated by black arrows. Homologous regions are shaded in grey. Nucleotide sequence identity was at least 95% in these regions</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13756_2019_563_Fig2_HTML.png" id="MO2"/></p></fig><fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>Comparative analysis of the whole genome sequences of Sag27 and Sag158 (CP019979). There are three segmental insertions in Sag27 compared to those in Sag158, including the lnu(B)-containing fragment (135–160 kb), ICESt1-related genes (1025–1050 kb), and ICESde3396 (2119–2184 kb)</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13756_2019_563_Fig3_HTML.png" id="MO3"/></p></fig></p></sec><sec id="Sec14" sec-type="conclusions"><title>Conclusion</title><p id="Par33">We reported three clinical <italic>S. agalactiae</italic> strains with the unusual resistance phenotype L<sup>R</sup>/M<sup>S</sup> mediated by <italic>lnu(B)</italic>. Our analyses of the genetic context and transferability of <italic>lnu(B)</italic> provide insight into the recent spread of rare resistance phenotypes in <italic>S. agalactiae</italic>.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>All authors have contributed equally to this work. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>This work was funded by Outstanding Leaders Training Program of Pudong Health Bureau of Shanghai (Grant No. PWRI2016–04) and Gaofeng Clinical Medicine Grant Support (project number2017269).</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The nucleotide sequences of Sag27/Sag4104 and the <italic>lnu(B)</italic>-carrying fragment of Sag3 have been deposited at DDBJ/ENA/GenBank under the accession numbers CP031556, SMRZ00000000, and MK102985, respectively.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par34">This study was approved by the ethics committee of Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China and the Review Board exempted the requirement for written informed consent because this is a retrospective study that only focused on bacteria and did not affect the patients.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par35">Not applicable.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par36">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Doare</surname><given-names>K</given-names></name><name><surname>Heath</surname><given-names>PT</given-names></name></person-group><article-title xml:lang="en">An overview of global GBS epidemiology</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><issue>Suppl 4</issue><fpage>D7</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">23973349</pub-id><pub-id pub-id-type="doi">10.1016/j.vaccine.2013.01.009</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigler</surname><given-names>K</given-names></name><name><surname>Spizek</surname><given-names>J</given-names></name><name><surname>Rezanka</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Medicinal use of Lincosamides and microbial resistance to them</article-title><source>Anti-Infective Agents in Medicinal Chemistry (Formerly â Current Medicinal Chemistry - Anti-Infective Agents)</source><year>2007</year><volume>6</volume><issue>2</issue><fpage>133</fpage><lpage>144</lpage></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeksema</surname><given-names>H</given-names></name><name><surname>Bannister</surname><given-names>B</given-names></name><name><surname>Birkenmeyer</surname><given-names>RD</given-names></name><name><surname>Kagan</surname><given-names>F</given-names></name><name><surname>Magerlein</surname><given-names>BJ</given-names></name><name><surname>Mackellar</surname><given-names>FA</given-names></name><name><surname>Schroeder</surname><given-names>W</given-names></name><name><surname>Slomp</surname><given-names>G</given-names></name><name><surname>Herr</surname><given-names>RR</given-names></name></person-group><article-title xml:lang="en">Chemical studies on Lincomycin. I. the structure of Lincomycin</article-title><source>J Am Chem Soc</source><year>1964</year><volume>86</volume><issue>19</issue><fpage>195</fpage><lpage>209</lpage></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allewelt</surname><given-names>M</given-names></name><name><surname>Schüler</surname><given-names>P</given-names></name><name><surname>Bölcskei</surname><given-names>PL</given-names></name><name><surname>Mauch</surname><given-names>H</given-names></name><name><surname>Lode</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Ampicillin + sulbactam vs. clindamycin ± cephalosporin for the treatment of aspiration pneumonia and primary lung abscess</article-title><source>Clin Microbiol Infect</source><year>2004</year><volume>10</volume><issue>2</issue><fpage>163</fpage><lpage>170</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXisF2hs7s%3D</pub-id><pub-id pub-id-type="pmid">14759242</pub-id><pub-id pub-id-type="doi">10.1111/j.1469-0691.2004.00774.x</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>JG</given-names></name></person-group><article-title xml:lang="en">Methicillin-resistant Staphylococcus aureus infections</article-title><source>Top HIV Med</source><year>2008</year><volume>16</volume><issue>5</issue><fpage>151</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">19106430</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>MD</given-names></name><name><surname>Decker</surname><given-names>CF</given-names></name></person-group><article-title xml:lang="en">Antimicrobial agents in treatment of MRSA infections</article-title><source>Dis Mon</source><year>2008</year><volume>54</volume><issue>12</issue><fpage>793</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">18996282</pub-id><pub-id pub-id-type="doi">10.1016/j.disamonth.2008.09.002</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Characterization of Spectinomycin resistance in Streptococcus suis leads to two novel insights into drug resistance formation and dissemination mechanism</article-title><source>Antimicrob Agents Chemother</source><year>2016</year><volume>60</volume><issue>10</issue><fpage>6390</fpage><lpage>6392</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtlKkt7c%3D</pub-id><pub-id pub-id-type="pmid">27458226</pub-id><pub-id pub-id-type="pmcid">5038275</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01157-16</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>PA</given-names></name><name><surname>Law</surname><given-names>CS</given-names></name><name><surname>Metcalf</surname><given-names>BJ</given-names></name><name><surname>Chochua</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>DM</given-names></name><name><surname>Westblade</surname><given-names>LF</given-names></name><name><surname>Jerris</surname><given-names>R</given-names></name><name><surname>Beall</surname><given-names>BW</given-names></name><name><surname>McGee</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Cross-resistance to lincosamides, streptogramins a and pleuromutilins in Streptococcus agalactiae isolates from the USA</article-title><source>J Antimicrob Chemother</source><year>2017</year><volume>72</volume><issue>7</issue><fpage>1886</fpage><lpage>1892</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhsFWktr7E</pub-id><pub-id pub-id-type="pmid">28333320</pub-id><pub-id pub-id-type="pmcid">5733627</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkx077</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achard</surname><given-names>A</given-names></name><name><surname>Villers</surname><given-names>C</given-names></name><name><surname>Pichereau</surname><given-names>V</given-names></name><name><surname>Leclercq</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36</article-title><source>Antimicrob Agents Chemother</source><year>2005</year><volume>49</volume><issue>7</issue><fpage>2716</fpage><lpage>2719</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXlvFSmu7s%3D</pub-id><pub-id pub-id-type="pmid">15980341</pub-id><pub-id pub-id-type="pmcid">1168647</pub-id><pub-id pub-id-type="doi">10.1128/AAC.49.7.2716-2719.2005</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozdogan</surname><given-names>B</given-names></name><name><surname>Berrezouga</surname><given-names>L</given-names></name><name><surname>Kuo</surname><given-names>MS</given-names></name><name><surname>Yurek</surname><given-names>DA</given-names></name><name><surname>Farley</surname><given-names>KA</given-names></name><name><surname>Stockman</surname><given-names>BJ</given-names></name><name><surname>Leclercq</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in enterococcus faecium HM1025</article-title><source>Antimicrob Agents Chemother</source><year>1999</year><volume>43</volume><issue>4</issue><fpage>925</fpage><lpage>929</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1MXisVSnsrg%3D</pub-id><pub-id pub-id-type="pmid">10103201</pub-id><pub-id pub-id-type="pmcid">89227</pub-id><pub-id pub-id-type="doi">10.1128/AAC.43.4.925</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Azavedo</surname><given-names>JC</given-names></name><name><surname>McGavin</surname><given-names>M</given-names></name><name><surname>Duncan</surname><given-names>C</given-names></name><name><surname>Low</surname><given-names>DE</given-names></name><name><surname>McGeer</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada</article-title><source>Antimicrob Agents Chemother</source><year>2001</year><volume>45</volume><issue>12</issue><fpage>3504</fpage><lpage>3508</lpage><pub-id pub-id-type="pmid">11709331</pub-id><pub-id pub-id-type="pmcid">90860</pub-id><pub-id pub-id-type="doi">10.1128/AAC.45.12.3504-3508.2001</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petinaki</surname><given-names>E</given-names></name><name><surname>Guerin-Faublee</surname><given-names>V</given-names></name><name><surname>Pichereau</surname><given-names>V</given-names></name><name><surname>Villers</surname><given-names>C</given-names></name><name><surname>Achard</surname><given-names>A</given-names></name><name><surname>Malbruny</surname><given-names>B</given-names></name><name><surname>Leclercq</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Lincomycin resistance gene lnu(D) in Streptococcus uberis</article-title><source>Antimicrob Agents Chemother</source><year>2008</year><volume>52</volume><issue>2</issue><fpage>626</fpage><lpage>630</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtlWjsr8%3D</pub-id><pub-id pub-id-type="pmid">18086844</pub-id><pub-id pub-id-type="doi">10.1128/AAC.01126-07</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Wendlandt</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Identification of the novel lincosamide resistance gene lnu(E) truncated by ISEnfa5-cfr-ISEnfa5 insertion in Streptococcus suis: de novo synthesis and confirmation of functional activity in Staphylococcus aureus</article-title><source>Antimicrob Agents Chemother</source><year>2014</year><volume>58</volume><issue>3</issue><fpage>1785</fpage><lpage>1788</lpage><pub-id pub-id-type="pmid">24366733</pub-id><pub-id pub-id-type="pmcid">3957883</pub-id><pub-id pub-id-type="doi">10.1128/AAC.02007-13</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arana</surname><given-names>DM</given-names></name><name><surname>Rojo-Bezares</surname><given-names>B</given-names></name><name><surname>Torres</surname><given-names>C</given-names></name><name><surname>Alos</surname><given-names>JI</given-names></name></person-group><article-title xml:lang="en">First clinical isolate in Europe of clindamycin-resistant group B Streptococcus mediated by the lnu(B) gene</article-title><source>Rev Esp Quimioter</source><year>2014</year><volume>27</volume><issue>2</issue><fpage>106</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">24940891</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Clinical and Laboratory Standards Institutes. Performance standards for antimicrobial susceptibility testing; 24th informational supplement, M100<bold>-</bold>S24. Wayne,PA 2014.</mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>JA</given-names></name><name><surname>Farmer</surname><given-names>KD</given-names></name><name><surname>Facklam</surname><given-names>RR</given-names></name></person-group><article-title xml:lang="en">Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type</article-title><source>J Clin Microbiol</source><year>1998</year><volume>36</volume><issue>7</issue><fpage>2115</fpage><lpage>2116</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK1czht12qug%3D%3D</pub-id><pub-id pub-id-type="pmid">9650978</pub-id><pub-id pub-id-type="pmcid">104994</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>BM</given-names></name><name><surname>Harding</surname><given-names>GP</given-names></name><name><surname>Zuccarelli</surname><given-names>AJ</given-names></name></person-group><article-title xml:lang="en">A general method for detecting and sizing large plasmids</article-title><source>Anal Biochem</source><year>1995</year><volume>226</volume><issue>2</issue><fpage>235</fpage><lpage>240</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2MXltVSrs70%3D</pub-id><pub-id pub-id-type="pmid">7793624</pub-id><pub-id pub-id-type="doi">10.1006/abio.1995.1220</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sletvold</surname><given-names>H</given-names></name><name><surname>Johnsen</surname><given-names>PJ</given-names></name><name><surname>Wikmark</surname><given-names>OG</given-names></name><name><surname>Simonsen</surname><given-names>GS</given-names></name><name><surname>Sundsfjord</surname><given-names>A</given-names></name><name><surname>Nielsen</surname><given-names>KM</given-names></name></person-group><article-title xml:lang="en">Tn1546 is part of a larger plasmid-encoded genetic unit horizontally disseminated among clonal enterococcus faecium lineages</article-title><source>J Antimicrob Chemoth</source><year>2010</year><volume>65</volume><issue>9</issue><fpage>1894</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtVansbvF</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkq219</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Partridge</surname><given-names>SR</given-names></name><name><surname>Kwong</surname><given-names>SM</given-names></name><name><surname>Firth</surname><given-names>N</given-names></name><name><surname>Jensen</surname><given-names>SO</given-names></name></person-group><article-title xml:lang="en">Mobile genetic elements associated with antimicrobial resistance</article-title><source>Clin Microbiol Rev</source><year>2018</year><volume>31</volume><issue>4</issue><fpage>e00088</fpage><lpage>e00017</lpage><pub-id pub-id-type="pmid">30068738</pub-id><pub-id pub-id-type="doi">10.1128/CMR.00088-17</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verani</surname><given-names>JR</given-names></name><name><surname>McGee</surname><given-names>L</given-names></name><name><surname>Schrag</surname><given-names>SJ</given-names></name></person-group><article-title xml:lang="en">Division of bacterial diseases NCfI, respiratory diseases CfDC, prevention: prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010</article-title><source>MMWR Recomm Rep</source><year>2010</year><volume>59</volume><issue>RR-10</issue><fpage>1</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">21088663</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castor</surname><given-names>ML</given-names></name><name><surname>Whitney</surname><given-names>CG</given-names></name><name><surname>Como-Sabetti</surname><given-names>K</given-names></name><name><surname>Facklam</surname><given-names>RR</given-names></name><name><surname>Ferrieri</surname><given-names>P</given-names></name><name><surname>Bartkus</surname><given-names>JM</given-names></name><name><surname>Juni</surname><given-names>BA</given-names></name><name><surname>Cieslak</surname><given-names>PR</given-names></name><name><surname>Farley</surname><given-names>MM</given-names></name><name><surname>Dumas</surname><given-names>NB</given-names></name><etal/></person-group><article-title xml:lang="en">Antibiotic resistance patterns in invasive group B streptococcal isolates</article-title><source>Infect Dis Obstet Gynecol</source><year>2008</year><volume>2008</volume><fpage>727505</fpage><pub-id pub-id-type="pmid">19223967</pub-id><pub-id pub-id-type="doi">10.1155/2008/727505</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Lopes E, Fernandes T, Machado MP, Carriço JA, Melo-Cristino J, Ramirez M, Martins ER. Increasing macrolide resistance among Streptococcus agalactiae causing invasive disease in non-pregnant adults was driven by a single capsular-transformed lineage. Portugal, 2009 to 2015. 2018;23(21).</mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betriu</surname><given-names>C</given-names></name><name><surname>Culebras</surname><given-names>E</given-names></name><name><surname>Gomez</surname><given-names>M</given-names></name><name><surname>Rodriguez-Avial</surname><given-names>I</given-names></name><name><surname>Sanchez</surname><given-names>BA</given-names></name><name><surname>Agreda</surname><given-names>MC</given-names></name><name><surname>Picazo</surname><given-names>JJ</given-names></name></person-group><article-title xml:lang="en">Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae</article-title><source>Antimicrob Agents Chemother</source><year>2003</year><volume>47</volume><issue>3</issue><fpage>1112</fpage><lpage>1114</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXhslWitb4%3D</pub-id><pub-id pub-id-type="pmid">12604549</pub-id><pub-id pub-id-type="pmcid">149330</pub-id><pub-id pub-id-type="doi">10.1128/AAC.47.3.1112-1114.2003</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Investigation of serotype distribution and resistance genes profile in group B Streptococcus isolated from pregnant women: a Chinese multicenter cohort study</article-title><source>APMIS</source><year>2016</year><volume>124</volume><issue>9</issue><fpage>794</fpage><lpage>799</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhtlOms77P</pub-id><pub-id pub-id-type="pmid">27452669</pub-id><pub-id pub-id-type="doi">10.1111/apm.12570</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faccone</surname><given-names>D</given-names></name><name><surname>Lalonardi</surname><given-names>F</given-names></name><name><surname>Abel</surname><given-names>S</given-names></name><name><surname>Machain</surname><given-names>M</given-names></name><name><surname>Errecalde</surname><given-names>L</given-names></name><name><surname>Littvik</surname><given-names>A</given-names></name><name><surname>Kauffman</surname><given-names>S</given-names></name><name><surname>Galas</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Group WH-A, Corso a: multiple-clones of Streptococcus agalactiae harbouring lnuB gene</article-title><source>J Infect Dev Ctries</source><year>2010</year><volume>4</volume><issue>9</issue><fpage>580</fpage><lpage>582</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXht1KlsL7F</pub-id><pub-id pub-id-type="pmid">21045372</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montilla</surname><given-names>A</given-names></name><name><surname>Zavala</surname><given-names>A</given-names></name><name><surname>Caceres Caceres</surname><given-names>R</given-names></name><name><surname>Cittadini</surname><given-names>R</given-names></name><name><surname>Vay</surname><given-names>C</given-names></name><name><surname>Gutkind</surname><given-names>G</given-names></name><name><surname>Famiglietti</surname><given-names>A</given-names></name><name><surname>Bonofiglio</surname><given-names>L</given-names></name><name><surname>Mollerach</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Genetic environment of the lnu(B) gene in a Streptococcus agalactiae clinical isolate</article-title><source>Antimicrob Agents Chemother</source><year>2014</year><volume>58</volume><issue>9</issue><fpage>5636</fpage><lpage>5637</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhs1equr3N</pub-id><pub-id pub-id-type="pmid">24957835</pub-id><pub-id pub-id-type="pmcid">4135823</pub-id><pub-id pub-id-type="doi">10.1128/AAC.02630-14</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XM</given-names></name><name><surname>Li</surname><given-names>XS</given-names></name><name><surname>Wang</surname><given-names>YB</given-names></name><name><surname>Wei</surname><given-names>FS</given-names></name><name><surname>Zhang</surname><given-names>SM</given-names></name><name><surname>Shang</surname><given-names>YH</given-names></name><name><surname>Du</surname><given-names>XD</given-names></name></person-group><article-title xml:lang="en">Characterization of a multidrug resistance plasmid from enterococcus faecium that harbours a mobilized bcrABDR locus</article-title><source>J Antimicrob Chemother</source><year>2015</year><volume>70</volume><issue>2</issue><fpage>609</fpage><lpage>611</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXivFGmu7s%3D</pub-id><pub-id pub-id-type="pmid">25324422</pub-id><pub-id pub-id-type="doi">10.1093/jac/dku416</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozano</surname><given-names>C</given-names></name><name><surname>Aspiroz</surname><given-names>C</given-names></name><name><surname>Saenz</surname><given-names>Y</given-names></name><name><surname>Ruiz-Garcia</surname><given-names>M</given-names></name><name><surname>Royo-Garcia</surname><given-names>G</given-names></name><name><surname>Gomez-Sanz</surname><given-names>E</given-names></name><name><surname>Ruiz-Larrea</surname><given-names>F</given-names></name><name><surname>Zarazaga</surname><given-names>M</given-names></name><name><surname>Torres</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Genetic environment and location of the lnu(a) and lnu(B) genes in methicillin-resistant Staphylococcus aureus and other staphylococci of animal and human origin</article-title><source>J Antimicrob Chemother</source><year>2012</year><volume>67</volume><issue>12</issue><fpage>2804</fpage><lpage>2808</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xhs1Gksr7K</pub-id><pub-id pub-id-type="pmid">22899804</pub-id><pub-id pub-id-type="doi">10.1093/jac/dks320</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Molecular characterization of Streptococcus agalactiae causing community- and hospital-acquired infections in Shanghai, China</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><fpage>1308</fpage><pub-id pub-id-type="pmid">27625635</pub-id><pub-id pub-id-type="pmcid">5003847</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">ICESag37, a novel integrative and conjugative element carrying antimicrobial resistance genes and potential virulence factors in Streptococcus agalactiae</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>1921</fpage><pub-id pub-id-type="pmid">29051752</pub-id><pub-id pub-id-type="pmcid">5633684</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.01921</pub-id></mixed-citation></ref></ref-list></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>CLSI</term><def><p id="Par5">Clinical and Laboratory Standards Institute</p></def></def-item><def-item><term>ICE</term><def><p id="Par6">Integrative and conjugative element</p></def></def-item><def-item><term>IS</term><def><p id="Par7">Insertion sequences</p></def></def-item><def-item><term>MIC</term><def><p id="Par8">The minimum inhibitory concentrations</p></def></def-item><def-item><term>ORF</term><def><p id="Par9">Open reading frame</p></def></def-item><def-item><term>PFGE</term><def><p id="Par10">Pulsed-field gel electrophoresis</p></def></def-item><def-item><term>TU</term><def><p id="Par11">Translocatable unit</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Biomedicine</facet-value><facet-value count="1">Drug Resistance</facet-value><facet-value count="1">Infectious Diseases</facet-value><facet-value count="1">Medical Microbiology</facet-value></facet><facet name="keyword"><facet-value count="1">
                lnu(B)
              </facet-value><facet-value count="1">
                S. agalactiae
              </facet-value><facet-value count="1">Composite transposon</facet-value><facet-value count="1">IS1216</facet-value><facet-value count="1">L phenotype</facet-value></facet><facet name="pub"><facet-value count="1">Antimicrobial Resistance &amp; Infection Control</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">China</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
